Forecasting News and Research

RSS

US most susceptible to brand erosion post patent expiry

On average, small molecule brands in the US experienced the greatest degree of brand erosion following patent expiry and exposure to direct generic competition, according to a new report from independent market analyst, Datamonitor.

12 Jan 2011

Stem cell therapy enters anti-aging industry

While many scientists may state that stem cells are the key to longer and healthier lives, some are not waiting on the technology for that and are using it in the anti-aging industry to bring unmatched results in wrinkle removal. The ant-wrinkle and skin cream industry has been in a state of remission as far as advancements in the industry for decades.

12 Jan 2011

Emergent BioSolutions estimates total revenue of $285 to $288 million for 2010

Emergent BioSolutions Inc. announced today preliminary, unaudited financial results for 2010 and guidance for 2011.

10 Jan 2011

Opinions: Global health top foreign policy issue; Global food security; Opiate-substitution programs in Eastern Europe; Feed the future; Foreign aid lessons

In response to a story examining 2011's top foreign policy issues, Serra Sippel, president of the Center for Health and Gender Equity, writes in a letter to the editor, published in The Hill, that "[g]lobal health was disturbingly absent from" the story. "Global health policy is at a critical turning point right now with the impending implementation of President Obama's Global Health Initiative, which will change our fundamental approach to health programs and policy," according to Sippel.

7 Jan 2011

State roundup: Facing budget 'cliff'; Medicaid woes; Arizona transplant program; Another Florida health vote?

U.S. states are preparing for more budget cuts next year as tax revenue isn't likely to rebound enough to replace almost $38 billion in aid that will be gone as federal economic stimulus ends, according to a report. At least 31 states and Puerto Rico are forecasting deficits of $82.1 billion in the next fiscal year even as tax receipts are picking up, the National Conference of State Legislatures said today.

10 Dec 2010

DecisionView releases StudyOptimizer 4.2 patient enrollment planning, tracking and forecasting solution

DecisionView Inc., a leading provider of software solutions to optimize clinical trial enrollment for life sciences companies, today announced the release of DecisionView StudyOptimizer 4.2, the latest version of the company's flagship solution for patient enrollment planning, tracking and forecasting. By providing better insight into historical enrollment performance and future cost projections, StudyOptimizer 4.2 significantly improves the ability of global pharmaceutical customers to optimize enrollment plans and deliver clinical trials on time and on budget.

1 Dec 2010

Precision Therapeutics to present abstracts on breast cancer therapy at San Antonio Symposium

Precision Therapeutics will present two abstracts at the 33rd Annual San Antonio Breast Cancer Symposium, which will be held December 8-12, 2010 in San Antonio, Texas.

1 Dec 2010

FAO report highlights 'alarmingly' high food price increases, forecasts food import bills could exceed $1T in 2010

International food import bills could exceed $1 trillion in 2010, the U.N. Food and Agriculture Organization (FAO) said Wednesday in its Food Outlook report, which found that wheat and other food staple prices have increased alarmingly over the past year, the Associated Press reports.

18 Nov 2010

Five Grand Challenges for Earth system

The international scientific community has identified five Grand Challenges that, if addressed in the next decade, will deliver knowledge to enable sustainable development, poverty eradication, and environmental protection in the face of global change. The Grand Challenges for Earth system science, published today, are the result of broad consultation as part of a visioning process spearheaded by the International Council for Science (ICSU) in cooperation with the International Social Science Council (ISSC).

12 Nov 2010

Meridian fourth quarter net sales decrease 16% to $35.5 million

Meridian Bioscience, Inc., reported fourth quarter and full-year fiscal 2010 net sales of $35.5 million and $143.0 million, respectively, decreases of 16% and 4%, respectively, from the same periods of the prior fiscal year.

11 Nov 2010

NxStage Medical third quarter net revenue increases 18% to $45.0 million

NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today reported record financial results for the third quarter of 2010 ended September 30, 2010.

4 Nov 2010

BioClinica third quarter service revenues increase to $15.8 million

BioClinica®, Inc., a global provider of clinical trial management services, today announced its financial results for the three and nine months ended September 30, 2010.

From Clario 3 Nov 2010

BioClinica enters five-year enterprise-wide agreement for Optimizer technology

BioClinica, Inc., a global provider of clinical trial management services, today announced that a Top Ten pharmaceutical company has entered into a five-year enterprise-wide agreement for BioClinica Optimizer to simulate and forecast clinical trial supply scenarios for their worldwide clinical trial operations.

From Clario 29 Oct 2010

Elan 2010 third quarter total revenue decreases 2% to $281.4 million

Elan Corporation, plc today reported its third quarter and first nine months 2010 financial results.

27 Oct 2010

Bristol-Myers Squibb 2010 third quarter U.S. net sales increases 4% to $3.1 billion

Bristol-Myers Squibb Company today reported results for the third quarter of 2010. Highlights in the quarter included: the presentation of new data on investigational compounds in the diabetes and cardiovascular disease franchises at major medical meetings; the completion of important regulatory milestones in the oncology, diabetes and immunoscience franchises; the acquisition of ZymoGenetics; and double-digit EPS growth. The company also confirmed guidance for 2010.

26 Oct 2010

Atrius selects Sightlines, DxCG Risk solutions for healthcare processes

Verisk Health, Inc., announced today that Atrius Health has selected Sightlines Medical Intelligence and DxCG Risk Solutions to identify, manage, and predict healthcare risk across its commercial, Medicaid, and Medicare populations.

20 Oct 2010

MRG data finds factors that drive single-port laparoscopy market

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, a combination of increased volume from current practitioners and growth in the number of surgeons performing the technique will drive the single-port laparoscopy market to over 100% growth over the next year, and to high double-digit growth past 2011.

19 Oct 2010

Health industry funding more Republicans than Dems, anti-reform political activity ramps up

Politico: "A new portrait of the health industry landscape has begun to take shape, with some of those major players shifting their dollars from the very Democrats who passed the law they seemingly endorsed at the White House. The insurance industry, for instance, has consistently donated more to Republicans than to Democrats ever since August 2009."

4 Oct 2010

Record number of Americans signed up for Medicaid last year, straining state budgets

Associated Press: "A record number of Americans signed up for Medicaid last year, as the recession wiped out jobs and workplace health coverage. A report released Thursday by the nonprofit Kaiser Family Foundation found that enrollment in the safety-net medical insurance program jumped to more than 48 million — a record 15.7 percent share of the U.S. population.

1 Oct 2010

Research Roundup: Medical homes; Drug samples and prescribing; The health law and disparities; Women's health; CBO projections

Institute of Medicine: Women's Health Research: Progress, Pitfalls, and Promise -"Substantial progress has been made since the expansion of investment in women's health research. Research findings have changed the practice of medicine and public-health recommendations in several prominent contexts, including changes in standards of care for women. There have also been decreases in mortality in women from breast cancer, heart disease, and cervical cancer. In other contexts, however, there has been less progress..."

24 Sep 2010